Lv1
20 积分 2022-09-19 加入
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC)
16小时前
求助中
Furmonertinib and intrathecal pemetrexed chemotherapy rechallenges osimertinib-refractory leptomeningeal metastasis in a non-small cell lung cancer patient harboring EGFR20 R776S, C797S, and EGFR21 L858R compound EGFR mutations: a case report
10天前
已完结
胸部肿瘤（一）：纵隔及胸壁（胸膜）肿瘤诊治——浙江省胸外科专家共识
2个月前
已完结
Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors
1年前
已完结
Coexistence of a secondary STRN–ALK, EML4–ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report
1年前
已完结
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer
2年前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2年前
已完结
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
2年前
已完结
皖公网安备34019202002308
